Nanoparticles Contract Manufacturing Market Report 2026

Nanoparticles Contract Manufacturing Market Overview

• Nanoparticles Contract Manufacturing market size has reached to $3.67 billion in 2025 • Expected to grow to $6.38 billion in 2030 at a compound annual growth rate (CAGR) of 11.5% • Growth Driver: The Role Of Research Investments In Driving Growth Of The Nanoparticle Contract Manufacturing Market • Market Trend: Innovation In Commercial Formulation Systems Enhances Competitiveness In Nanoparticle Contract Manufacturing Market • North America was the largest region in 2025.

What Is Covered Under Nanoparticles Contract Manufacturing Market?

Nanoparticle contract manufacturing refers to the outsourcing of the production of nanoparticles to third-party manufacturers or contract manufacturing organizations (CMOs). They serve as a versatile solution for various industries, offering tailored nanoparticle formulations and expertise to meet specific application requirements and drive innovation in diverse fields. The main types of nanoparticles contract manufacturing market are metal nanoparticles, lipid nanoparticles, and other nanoparticles. Metal nanoparticles are tiny particles of metal with dimensions typically in the range of 1 to 100 nanometers. The various manufacturing scales include commercial, clinical, and pre-clinical used for various applications such as therapeutics, diagnostics, and vaccines used by various end-users including pharmaceutical companies, and biotechnology companies.

What Is The Nanoparticles Contract Manufacturing Market Growth Forecast?

The nanoparticles contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $6.38 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of mrna vaccine manufacturing, increasing biotech outsourcing demand, advancements in nanoparticle engineering, rising investments in nanotechnology infrastructure, growth of precision medicine applications. Major trends in the forecast period include rising outsourcing of nanoparticle production, increasing adoption of lipid nanoparticles in drug delivery, expansion of clinical-scale manufacturing capabilities, growing demand for customized nanoparticle formulations, increased focus on quality compliance and regulatory alignment.

Global Nanoparticles Contract Manufacturing Market Segmentation

1) By Type Of Nanoparticle: Metal Nanoparticles, Lipid Nanoparticles, Other Types Of Nanoparticles 2) By Manufacturing Scale: Commercial, Clinical, Pre-Clinical 3) By Application: Therapeutics, Diagnostics, Vaccines 4) By End-User: Pharmaceutical Companies, Biotechnology Companies Subsegments: 1) By Metal Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Copper Nanoparticles, Iron Nanoparticles 2) By Lipid Nanoparticles: Solid Lipid Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs), Lipid-Core Micelles 3) By Other Types of Nanoparticles: Polymeric Nanoparticles, Carbon Nanotubes, Quantum Dots, Dendrimers

What Is The Driver Of The Nanoparticles Contract Manufacturing Market?

The surge in research investments is expected to propel the growth of the nanoparticle contract manufacturing market. Research investments refer to financial resources allocated toward conducting research activities aimed at generating new knowledge, advancing scientific understanding, developing innovative technologies, or solving specific problems. Research investments are increasing due to several factors, such as the focus on innovation and technology, rising awareness of societal challenges, support for emerging technologies, policy support and long-term planning, and government funding initiatives. Research investments are essential for the advancement of nanoparticle contract manufacturing because they promote technological innovation, customization, quality control, scalability, cross-disciplinary cooperation, market expansion, and economic growth. For instance, in April 2023, according to the House of Commons, a UK-based governing body, the Chancellor declared a substantial increase in public Research and Development (R&D) expenditures, aiming to raise the budget to £22 billion ($27.64 billion) by fiscal year 2024–2025 from approximately £9 billion ($11.30 billion) in the previous year, amounting to 0.8% of GDP, reflecting a commitment to enhancing R&D efforts and driving innovation domestically. Therefore, the surge in research investments is driving the growth of the nanoparticle contract manufacturing market.

Key Players In The Global Nanoparticles Contract Manufacturing Market

Major companies operating in the nanoparticles contract manufacturing market are Evonik Industries AG, CordenPharma International GmbH, Ajinomoto Bio-Pharma Services, BioVectra Inc., Fortis Life Sciences, LSNE Contract Manufacturing, Precision NanoSystems Inc., Ardena Holding NV, American Elements, Polymun Scientific Immunbiologische Forschung GmbH, Hitachi Chemical Advanced Therapeutics Solutions LLC, Axolabs GmbH, Cytodiagnostics Inc., Encapsula NanoSciences LLC, Nanochemazone, TechNano India, Lonza, Phosphorex, TRANSFERRA Nanosciences Inc, DIANT Pharma, Nano Labs Corporation, Nanoscale Corporation

Global Nanoparticles Contract Manufacturing Market Trends and Insights

Major companies operating in the nanoparticle contract manufacturing market are developing innovative technologies, such as commercial formulation systems, to produce medicines for clinical and commercial manufacturing and gain a competitive edge in the market. A commercial formulation system refers to a comprehensive platform designed for the efficient development and production of nanoparticle-based products. For instance, in July 2023, Cytiva, a US-based provider of life sciences products and solutions, launched the NanoAssemblr commercial formulation system. This system is designed to minimize the risk of cross-contamination, which is particularly important for genomic medicines. It utilizes a single-use fluid path that helps boost production by minimizing downtime for sanitizing and cleaning, allowing for the manufacture of multiple lipid nanoparticle products within the same facility. The system is powered by 21 CFR Part 11-compliant software that enables electronic batch records, captures in-process monitoring of flow rate, and automates the priming, calibrating, formulating, and in-line dilution processes.

What Are Latest Mergers And Acquisitions In The Nanoparticles Contract Manufacturing Market?

In May 2025, PCI Pharma Services, a US-based provider of sterile fill-finish manufacturing and advanced drug delivery solutions, acquired Ajinomoto Althea for an undisclosed amount. With this acquisition, PCI aims to expand its aseptic fill-finish capacity, strengthen its advanced modality manufacturing capabilities including nanoparticles, mRNA, peptides, and antibody-drug conjugates and establish a large-scale U.S. hub for end-to-end injectable drug product development. Ajinomoto Althea is a US–based provider of sterile fill-finish services, customized biologics manufacturing, and complex formulation capabilities across injectables such as nanoparticles, oligonucleotides, peptides, and high-potency biologics.

Regional Outlook

North America was the largest region in the nanoparticles contract manufacturing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nanoparticles Contract Manufacturing Market?

The nanoparticle contract manufacturing market includes revenues earned by entities by providing services such as custom synthesis, scale-up production, and surface modification and functionalization and related drug delivery nanoparticles, diagnostic nanoparticles, cosmetic nanoparticles, and electronic nanoparticles. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nanoparticles Contract Manufacturing Market Report 2026?

The nanoparticles contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nanoparticles contract manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.